Clinical Trial Update: A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis. [Phase 3]

View source ↗

Summary

A Phase 3 study assessing subcutaneous C.E.R.A. (methoxy polyethylene glycol-epoetin beta) for maintaining hemoglobin levels in adults with chronic renal anemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• C.E.R.A. (methoxy polyethylene glycol-epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-11-07